TY - JOUR
T1 - Identification of potential disease-associated variants in idiopathic generalized epilepsy using targeted sequencing
AU - Gamirova, Regina
AU - Shagimardanova, Elena
AU - Sato, Takehiro
AU - Kannon, Takayuki
AU - Gamirova, Rimma
AU - Tajima, Atsushi
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to The Japan Society of Human Genetics.
PY - 2024/2
Y1 - 2024/2
N2 - Many questions remain regarding the genetics of idiopathic generalized epilepsy (IGE), a subset of genetic generalized epilepsy (GGE). We aimed to identify the candidate coding variants of epilepsy panel genes in a cohort of affected individuals, using variant frequency information from a control cohort of the same region. We performed whole-exome sequencing analysis of 121 individuals and 10 affected relatives, focusing on variants of 950 candidate genes associated with epilepsy according to the Genes4Epilepsy curated panel. We identified 168 candidate variants (CVs) in 137 of 950 candidate genes in 88 of 121 affected individuals with IGE, of which 61 were novel variants. Notably, we identified five CVs in known GGE-associated genes (CHD2, GABRA1, RORB, SCN1A, and SCN1B) in five individuals and CVs shared by affected individuals in each of four family cases for other epilepsy candidate genes. The results of this study demonstrate that IGE is a disease with high heterogeneity and provide IGE-associated CVs whose pathogenicity should be proven by future studies, including advanced functional analysis. The low detection rate of CVs in the GGE-associated genes (4.1%) in this study suggests the current incompleteness of the Genes4Epilepsy panel for the diagnosis of IGE in clinical practice.
AB - Many questions remain regarding the genetics of idiopathic generalized epilepsy (IGE), a subset of genetic generalized epilepsy (GGE). We aimed to identify the candidate coding variants of epilepsy panel genes in a cohort of affected individuals, using variant frequency information from a control cohort of the same region. We performed whole-exome sequencing analysis of 121 individuals and 10 affected relatives, focusing on variants of 950 candidate genes associated with epilepsy according to the Genes4Epilepsy curated panel. We identified 168 candidate variants (CVs) in 137 of 950 candidate genes in 88 of 121 affected individuals with IGE, of which 61 were novel variants. Notably, we identified five CVs in known GGE-associated genes (CHD2, GABRA1, RORB, SCN1A, and SCN1B) in five individuals and CVs shared by affected individuals in each of four family cases for other epilepsy candidate genes. The results of this study demonstrate that IGE is a disease with high heterogeneity and provide IGE-associated CVs whose pathogenicity should be proven by future studies, including advanced functional analysis. The low detection rate of CVs in the GGE-associated genes (4.1%) in this study suggests the current incompleteness of the Genes4Epilepsy panel for the diagnosis of IGE in clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=85177566327&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85177566327&partnerID=8YFLogxK
U2 - 10.1038/s10038-023-01208-3
DO - 10.1038/s10038-023-01208-3
M3 - Article
C2 - 37993639
AN - SCOPUS:85177566327
SN - 1434-5161
VL - 69
SP - 59
EP - 67
JO - Journal of Human Genetics
JF - Journal of Human Genetics
IS - 2
ER -